Courtney Andersen studies the role of estrogen receptor-alpha in ovarian cancer.
Chris Barnes investigates the structural details by which transcription factor activity regulates RNA Polymerase II during the universal process of eukaryotic gene expression.
Soma Jobaggy studies nitrated fatty acid pharmacology and the antioxidant response in hypertensive end-organ damage.
Allison Nagle studies growth factor receptor signaling in breast cancer.
Vera Procaccia
Graduate Student Researcher


Bisello Lab

W1313 Thomas E. Starzl Biomedical Science Tower


BSc Med, Basic Medical Sciences, The Hebrew University, 2005
MSc, Developmental Biology, The Hebrew University, 2009

Awards Received
Louis J. Ignarro Cardiovascular Pharmacology Fellowship 2015

Faculty Mentor
Dr. Alessandro Bisello
W1313 Thomas E. Starzl Biomedical Science Tower
Photo of Vera Procaccia

Procaccia V, Nakayama H, Shimizu A, Klagsbrun M.Gleevec/imatinib, an ABL2 kinase inhibitor, protects tumor and endothelial cells from semaphorin-induced cytoskeleton collapse and loss of cell motility. Biochem Biophys Res Commun. 2014 May 30;448(2):134-8. doi: 10.1016/j.bbrc.2014.04.063. Epub 2014 Apr 20. PMID: 24759231 PMCID: PMC4068341


3/22/2018 12:00 PM Pharmacology & Chemical Biology Seminar Series
David Harrison, M.D.

3/29/2018 12:00 PM Pharmacology & Chemical Biology Seminar Series
Yuanyuan Chen, Ph.D.

4/3/2018 12:00 PM Pharmacology & Chemical Biology Special Seminar
Craig J. Burd, Ph.D.

Pharmacology and Chemical Biology Event Calendar

Program Achievements

Molecular Pharmacology Graduate Program Ranked #2 in National Research Council Rankings

Outcomes:  Time to disseration, last five graduating clasess:  4.5 years, Completion Rate: 84.8%

Ranked #12 in National of Institute of Health funding of departments of Pharmacology

Ranked in the top 15 in funding for twenty two consecutive years

Back to Top